141 related articles for article (PubMed ID: 31212137)
21. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
[TBL] [Abstract][Full Text] [Related]
22. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.
Heimlich JM; Regnier FE; White JL; Hem SL
Vaccine; 1999 Jul; 17(22):2873-81. PubMed ID: 10438058
[TBL] [Abstract][Full Text] [Related]
23. Characterization of aluminium-containing adjuvants.
White JL; Hem SL
Dev Biol (Basel); 2000; 103():217-28. PubMed ID: 11214239
[TBL] [Abstract][Full Text] [Related]
24. Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins.
Rinella JV; White JL; Hem SL
Vaccine; 1996 Mar; 14(4):298-300. PubMed ID: 8744556
[TBL] [Abstract][Full Text] [Related]
25. Aluminium phosphate adjuvants prepared by precipitation at constant pH. Part I: composition and structure.
Burrell LS; Johnston CT; Schulze D; Klein J; White JL; Hem SL
Vaccine; 2000 Sep; 19(2-3):275-81. PubMed ID: 10930682
[TBL] [Abstract][Full Text] [Related]
26. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
[TBL] [Abstract][Full Text] [Related]
27. Predicting the adsorption of proteins by aluminium-containing adjuvants.
Seeber SJ; White JL; Hem SL
Vaccine; 1991 Mar; 9(3):201-3. PubMed ID: 2042392
[TBL] [Abstract][Full Text] [Related]
28. Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II.
Aggerbeck H; Fenger C; Heron I
Vaccine; 1995 Oct; 13(14):1366-74. PubMed ID: 8585295
[TBL] [Abstract][Full Text] [Related]
29. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.
Mumford JA; Wilson H; Hannant D; Jessett DM
Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017
[TBL] [Abstract][Full Text] [Related]
30. Results obtained with diphtheria phosphate toxoid.
TASMAN A; LEBRET JD
Bull World Health Organ; 1954; 10(6):951-82. PubMed ID: 13199659
[TBL] [Abstract][Full Text] [Related]
31. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
Maa YF; Zhao L; Payne LG; Chen D
J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
[TBL] [Abstract][Full Text] [Related]
32. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies.
Destexhe E; Prinsen MK; van Schöll I; Kuper CF; Garçon N; Veenstra S; Segal L
J Pharmacol Toxicol Methods; 2013; 68(3):367-73. PubMed ID: 23624216
[TBL] [Abstract][Full Text] [Related]
34. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
35. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits.
Chang M; Shi Y; Nail SL; HogenEsch H; Adams SB; White JL; Hem SL
Vaccine; 2001 Apr; 19(20-22):2884-9. PubMed ID: 11282199
[TBL] [Abstract][Full Text] [Related]
36. The effect of aluminium phosphate adjuvant on the potency of pertussis vaccine.
Gupta RK; Sharma SB; Ahuja S; Saxena SN
J Biol Stand; 1987 Jan; 15(1):99-101. PubMed ID: 3558423
[No Abstract] [Full Text] [Related]
37. Uric acid and the vaccine adjuvant activity of aluminium (oxy)hydroxide nanoparticles.
Thakkar SG; Xu H; Li X; Cui Z
J Drug Target; 2018; 26(5-6):474-480. PubMed ID: 29334279
[TBL] [Abstract][Full Text] [Related]
38. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
Shi Y; HogenEsch H; Hem SL
Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
[TBL] [Abstract][Full Text] [Related]
39. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
[TBL] [Abstract][Full Text] [Related]
40. Nanoalum adjuvanted vaccines: small details make a big difference.
Raponi A; Brewer JM; Garside P; Laera D
Semin Immunol; 2021 Aug; 56():101544. PubMed ID: 34895823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
